.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
McKinsey
Citi
Boehringer Ingelheim
AstraZeneca
Baxter
Covington
McKesson
Chinese Patent Office
Merck

Generated: September 24, 2017

DrugPatentWatch Database Preview

UTIMOX Drug Profile

« Back to Dashboard

Which patents cover Utimox, and what generic Utimox alternatives are available?

Utimox is a drug marketed by Parke Davis and is included in two NDAs.

The generic ingredient in UTIMOX is amoxicillin. There are forty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

Summary for Tradename: UTIMOX

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list36
Patent Applications: see list5,217
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:UTIMOX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
UTIMOX
amoxicillin
CAPSULE;ORAL062107-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
UTIMOX
amoxicillin
FOR SUSPENSION;ORAL062127-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
UTIMOX
amoxicillin
CAPSULE;ORAL062107-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
UTIMOX
amoxicillin
FOR SUSPENSION;ORAL062127-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
US Army
Daiichi Sankyo
AstraZeneca
Chinese Patent Office
Dow
Harvard Business School
Chubb
Citi
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot